Although some experimental and clinical studies have evaluated the pathophysiological role of RAGE in asthma [42–44], this study, to the best of our knowledge, is the first that has evaluated the association of RAGE genetic variants with asthma risk, and our findings identified a promoter marker in significant predisposition to asthma, which requires additional validation in other independent populations. Here, AGER is linked to asthma.